| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/06/2007 | WO2007138114A1 Use of prodrugs for ocular intravireous administration |
| 12/06/2007 | WO2007138113A1 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 12/06/2007 | WO2007137847A1 Process for production of a vaccine composition |
| 12/06/2007 | WO2007137846A1 Process for production of a vaccine composition |
| 12/06/2007 | WO2007137755A1 Peg-modified arginine/lysine oxidoreductase |
| 12/06/2007 | WO2007115381A3 Solid dispersion of poorly soluble drugs in graft copolymers |
| 12/06/2007 | WO2007103873A3 Pharmaceutical formulations of an anhydrous crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 12/06/2007 | WO2007103869A3 Liquid and semi-solid pharmaceutical formulations and processes |
| 12/06/2007 | WO2007098467A3 Stable vitamin c compositions |
| 12/06/2007 | WO2007053533A3 Sodium chloride solution for drug reconstitution or dilution |
| 12/06/2007 | WO2007044375A3 Pth formulations and methods of use |
| 12/06/2007 | WO2007010584A3 Controlled-delivery system of pharmacologically active substances, preparation process and medical use thereof |
| 12/06/2007 | WO2007000669A3 Use of conjugates with linkers cleavable by photodissociation or fragmentation for mass spectrometry analysis of tissue sections |
| 12/06/2007 | WO2006122183A3 Injectable hydrogels and methods of making and using same |
| 12/06/2007 | WO2006118547A8 Hyperbranched polymers and their applications |
| 12/06/2007 | WO2006108692A3 Dosage form for oral administration of a vitamin |
| 12/06/2007 | WO2005086612A3 Fluorinated carbohydrate conjugates |
| 12/06/2007 | WO2005072141A3 Peptide inhibitors of rhoa signaling |
| 12/06/2007 | WO2004064109A3 Water soluble metal and semiconductor nanoparticle complexes |
| 12/06/2007 | US20070282032 Compositions and methods for inhibiting protein on surfaces |
| 12/06/2007 | US20070282015 Novel Splice Variants of Human Dkkl1 |
| 12/06/2007 | US20070282014 Hydroxyethylstarch |
| 12/06/2007 | US20070282013 Pharmaceutical Compositions Comprising Peranhydrocyclodextrin |
| 12/06/2007 | US20070282009 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 12/06/2007 | US20070281926 Rectal Composition |
| 12/06/2007 | US20070281878 Particle-Stabilised Emulsions |
| 12/06/2007 | US20070281036 System and method of delivering a desired material to a cell |
| 12/06/2007 | US20070281025 Cholesterol-Interacting Layered Phyllosilicates and Methods of Reducing Hypercholesteremia in a Mammal |
| 12/06/2007 | US20070280999 Orally administrable composition for the photoprotection of the skin |
| 12/06/2007 | US20070280996 Dietary supplement having improved efficacy at time of consumption |
| 12/06/2007 | US20070280980 Percutaneous Pharmaceutical Preparation for External Use Containing Nonsteroidal Antiinflammatory Analgesic |
| 12/06/2007 | US20070280979 Solid Oil-In-Water Emulsion |
| 12/06/2007 | US20070280977 Multiple Emulsion Excipient for Cosmetic Actives |
| 12/06/2007 | US20070280972 Adhesive solid gel-forming formulations for dermal drug delivery |
| 12/06/2007 | US20070280952 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 12/06/2007 | US20070280932 Binding to monoclonal antibodies; antitumor agents |
| 12/06/2007 | US20070280924 Pharmaceutical Preparations For And Treatment Of Ocular Surface and Other Disorders |
| 12/06/2007 | US20070280916 Pharmaceutical Formulations Comprising Paraoxonase |
| 12/06/2007 | US20070280910 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
| 12/06/2007 | US20070280899 Polyhydroxyalkanoates for In Vivo Applications |
| 12/06/2007 | US20070280881 Dimeric antibody having two antibodies that are non-covalently associated to form a tetravalent antibody dimer having four antigen-biding sites; neoplastic disorders such as colon cancer; autoimmune disorders |
| 12/06/2007 | CA2686155A1 Pharmacological treatment of cognitive impairment |
| 12/06/2007 | CA2657276A1 Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same |
| 12/06/2007 | CA2653920A1 Composition for controlling snoring, in the form of a nasal spray |
| 12/06/2007 | CA2653916A1 Nasal and buccal compositions for controlling snoring |
| 12/06/2007 | CA2653902A1 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 12/06/2007 | CA2653741A1 Controlled release of phenolic opioids |
| 12/06/2007 | CA2653365A1 Peg-modified arginine/lysine oxidoreductase |
| 12/06/2007 | CA2653283A1 Compositions and methods for treating conditions of the nail unit |
| 12/06/2007 | CA2653023A1 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid or sa lt thereof |
| 12/06/2007 | CA2652945A1 Antibodies and immunoconjugates and uses therefor |
| 12/06/2007 | CA2651737A1 Barrier film-forming germicidal composition for controlling mastitis |
| 12/06/2007 | CA2650510A1 Materials and complexes for the delivery of biologically-active material to cells |
| 12/06/2007 | CA2648987A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof |
| 12/05/2007 | EP1862546A1 Enhanced virus-mediated dna transfer |
| 12/05/2007 | EP1862544A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 12/05/2007 | EP1862475A1 Polymer conjugates of neublastin and methods of using same |
| 12/05/2007 | EP1862470A1 Element retained in blood showing degradability selectively in tumor tissue |
| 12/05/2007 | EP1862184A1 Pharmaceutical composition |
| 12/05/2007 | EP1862183A1 Pharmaceutical composition containing hardly water soluble medicament |
| 12/05/2007 | EP1862177A1 Method for producing a vaccine composition |
| 12/05/2007 | EP1862176A1 Method for producing a vaccine composition |
| 12/05/2007 | EP1862174A1 Inhibitor for insulin polymer formation |
| 12/05/2007 | EP1862164A2 Dry powder for inhalation |
| 12/05/2007 | EP1862161A1 Injectable pharmaceutical, cosmetic compositions and/or medical devices on the basis of hyaluronic-acid |
| 12/05/2007 | EP1861125A2 Conjugates of an hgh moiety and peg derivatives |
| 12/05/2007 | EP1861124A2 Production of bioactive glycoproteins from inactive starting materials by conjugation with hydroxyalkylstarch |
| 12/05/2007 | EP1861116A2 Vegf antagonist formulations |
| 12/05/2007 | EP1861110A1 Antibiotic combinations for providing total solution to the treatment of infections |
| 12/05/2007 | EP1861084A1 Improved formulations of fenofibrate containing menthol or peg/poloxamer |
| 12/05/2007 | EP1861082A1 A topical composition and its uses |
| 12/05/2007 | EP1861076A2 A transdermal topical composition and its uses |
| 12/05/2007 | EP1861073A2 Process for the production of calcium compositions in a continuous fluid bed |
| 12/05/2007 | EP1861071A2 Deliver of molecules to a li id bila |
| 12/05/2007 | EP1608335B1 Controlled release system containing saccharose acetate isobutyrate |
| 12/05/2007 | EP1501522A4 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents |
| 12/05/2007 | EP1497411A4 Embryo modification and implantation |
| 12/05/2007 | EP1492876B1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof |
| 12/05/2007 | EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof |
| 12/05/2007 | EP1381393B1 Microparticle protection of therapeutic agents |
| 12/05/2007 | EP1368318B1 Calcilytic compounds |
| 12/05/2007 | EP1339440B1 An implantable or insertable therapeutic agent delivery device |
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 12/05/2007 | EP1282446B1 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid |
| 12/05/2007 | EP1248599B1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
| 12/05/2007 | EP1223976B1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 12/05/2007 | EP1170006B1 Drug for alleviating migrane |
| 12/05/2007 | EP1073418B1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |
| 12/05/2007 | CN101084017A Bioadhesive composition with programmed release |
| 12/05/2007 | CN101084016A Compositions capable of facilitating penetration across a biological barrier |
| 12/05/2007 | CN101084015A Antibody formulation in histidine-acetate buffer |
| 12/05/2007 | CN101084013A Cancerous disease modifying antibodies |
| 12/05/2007 | CN101084008A Therapeutic formulations of keratinocyte growth factor |
| 12/05/2007 | CN101083981A Flavonoid composition for treating oral diseases |
| 12/05/2007 | CN101083907A Compositions and methods for topical diagnostic and therapeutic transport |
| 12/05/2007 | CN101082042A Application of artificial reconstructed defect type human 3-type adenovirus |
| 12/05/2007 | CN101081876A Subcellular organelle target directional Chitosan oligosaccharide-aliphatic acid grafting matter and preparation and application thereof |
| 12/05/2007 | CN101081302A Process for preparing original position of nanometer laminated composite material |
| 12/05/2007 | CN101081301A Medicinal composition containing pemetrexed |
| 12/05/2007 | CN101081234A Method for preparation of claybank propolis soft capsules |